ArticleClinical and experimental hepatology2023

Effects of body composition and liver function after long-term pemafibrate treatment on dyslipidemia-associated non-alcoholic fatty liver disease.

Toru Ishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.